BioCentury
ARTICLE | Financial News

Voyager raises $54M follow-on

November 10, 2017 8:46 PM UTC

On Nov. 7, gene therapy company Voyager Therapeutics Inc. (NASDAQ:VYGR) raised $54 million through the sale of 4.5 million shares at $12 in a follow-on underwritten by Morgan Stanley, Cowen, Stifel, Wells Fargo and Nomura. The price is a 27% discount to Voyager's close of $16.54 on Nov. 6, when it proposed after hours to raise $75 million.

In September, the company reported that VY-AADC01 led to durable, dose-dependent improvements across multiple measures of motor function in a Phase Ib trial in Parkinson's disease patients (see BioCentury, Sept 8)...